Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.
about
Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillationAtrial Electrophysiological Remodeling and Fibrillation in Heart FailureDifferential regulation of EHD3 in human and mammalian heart failure.Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.Mitochondrial DNA 4977bp deletion mutation in peripheral blood reflects atrial remodeling in patients with non-valvular atrial fibrillation.Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial.Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation.Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.Heart failure duration progressively modulates the arrhythmia substrate through structural and electrical remodeling.Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology.Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts.Systems Pharmacology Dissection of the Integrated Treatment for Cardiovascular and Gastrointestinal Disorders by Traditional Chinese MedicineAntioxidant therapies for the management of atrial fibrillation.The NO/ONOO-cycle as the central cause of heart failure.Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Association evidence of CCTTT repeat polymorphism in the iNOS promoter and the risk of atrial fibrillation in Taiwanese.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Atrial fibrillation in heart failure.Atrial fibrillation in the elderly: the potential contribution of reactive oxygen species.Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.The 894G Allele of the Endothelial Nitric Oxide Synthase 3 (eNOS) is Associated with Atrial Fibrillation in Chronic Systolic Heart Failure.The effects of kisspeptin-10 on serum metabolism and myocardium in rats.Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.Nitric oxide synthases and atrial fibrillationHPLC analysis of tetrahydrobiopterin and its pteridine derivatives using sequential electrochemical and fluorimetric detection: application to tetrahydrobiopterin autoxidation and chemical oxidation.Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.Amino Acid-Based Metabolic Panel Provides Robust Prognostic Value Additive to B-Natriuretic Peptide and Traditional Risk Factors in Heart Failure
P2860
Q26770909-F6DC017A-3799-45F1-A5CC-732A08ACF4DBQ28066307-82746032-4D32-4F38-9781-47CA29834DB4Q34260282-2274B83A-310F-420D-B9FC-002D5B8AE691Q34651371-37CC472E-A8D0-417E-9035-527163DDEE48Q34774244-40A7B1B0-3479-4219-ABD7-32F2F65CD4D4Q36141379-EF2E36D7-7F27-42A6-94AC-E4F09584A258Q36174383-EABFC2B6-C8B1-4A5C-8FB9-C1CDA207FCB8Q36193817-CB661689-C8BC-4563-9F47-0120274229BFQ36359544-B9580ADA-402C-498E-AA65-9BF95D4398E2Q36606988-1C1758D0-7B44-4E2C-BF90-0A83665CFB30Q36828341-B154B8B7-0607-49A3-BA3B-8FAEB02AAC36Q36975420-836E00AF-391B-495D-A01A-830160DC7305Q36986257-EE308DB2-2C8C-4DBC-8570-0873FFEA6806Q37144494-0AE1FA38-9D3E-46E7-A36C-EE66D8F8B169Q37232687-89CD9469-1774-43BB-BDAF-9EBF9DB50A28Q37339307-8790C4D4-FAAB-4D91-B2F8-3670E8A265FCQ37375441-7B75D39C-B2A7-4FFD-8C76-BD8FB085586CQ37602866-F3EBA7AF-2B3A-43CA-8567-EEFDB670894FQ37638221-78DD7510-8726-46EC-A503-07070AF8BE9DQ37968218-E37E4FC7-0C97-4FBA-BDAF-9FD694CDD562Q38032181-23811B6B-6309-4D00-85BD-A08FD1ABBE43Q38076111-53C2A48C-5F13-4A4C-BA69-FCB764FBBD8AQ38202561-C82A193C-3ACA-49AA-ADAD-D90248372E52Q38703115-AA995100-F8AB-4CF0-9748-A75C8EC7B0E6Q38790603-57F8227A-712F-434C-953F-AF646A0AC485Q40968987-80EA94E4-E189-42A3-A551-68F3199EC2DEQ41620104-65668EDB-D32D-40BA-B39F-D20E34838986Q42535395-43DF4D6C-1619-4D03-B5D2-E2547D91ACB6Q42576287-C2E5EF95-4BF1-4229-B543-918E14CFC4ADQ46706302-84AD6949-BEA6-4C82-908C-FBE17C6D2234Q58575444-1B4DCCA6-53A2-4E9E-B748-C6CCBD988BD2
P2860
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@ast
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@en
type
label
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@ast
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@en
prefLabel
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@ast
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@en
P2093
P2860
P356
P1476
Tetrahydrobiopterin depletion ...... s in atrial electrophysiology.
@en
P2093
Arturo J Cardounel
Arun Sridhar
Cynthia A Carnes
Dmitry Terentyev
Jay L Zweier
Mahmood Khan
Murugesan Velayutham
Periannan Kuppusamy
Radmila Terentyeva
P2860
P356
10.1093/CVR/CVR087
P577
2011-04-01T00:00:00Z